135 related articles for article (PubMed ID: 35248753)
1. Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study.
Ross AJ; Ross BJ; Lee OC; Hood HW; Sanchez FL; Sherman WF
J Arthroplasty; 2022 Jul; 37(7):1326-1332.e3. PubMed ID: 35248753
[TBL] [Abstract][Full Text] [Related]
2. A Missed Opportunity: The Impact of Hepatitis C Treatment Prior to Total Knee Arthroplasty on Postoperative Complications.
Ross AJ; Ross BJ; Lee OC; Weldy JM; Sherman WF; Sanchez FL
J Arthroplasty; 2022 Apr; 37(4):709-713.e2. PubMed ID: 34954018
[TBL] [Abstract][Full Text] [Related]
3. Does pre-arthroplasty antiviral treatment for hepatitis C reduce complication rates after total shoulder arthroplasty? A matched cohort study.
Ross AJ; Ross BJ; Lee OC; Williams GH; Savoie FH; O'Brien MJ; Sanchez FL; Sherman WF
JSES Int; 2022 Nov; 6(6):910-916. PubMed ID: 36353415
[TBL] [Abstract][Full Text] [Related]
4. Curtailing infection risks in hepatitis C patients: the effect of antiviral treatment in revision shoulder arthroplasty.
Hameed D; Shear B; Dubin J; Remily E; Bains SS; Chen Z; Mont MA; Hasan SA; Gilotra MN
J Shoulder Elbow Surg; 2024 Jul; 33(7):1528-1535. PubMed ID: 38104720
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Treatment for Hepatitis C Is Associated With a Reduced Risk of Periprosthetic Joint Infection: A Meta-Analysis of Observational Studies.
Cheng T; Xu D; Yan Z; Ding C; Yang C; Zhang X
J Arthroplasty; 2022 Sep; 37(9):1870-1878. PubMed ID: 35483609
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US Veterans.
Bendich I; Takemoto S; Patterson JT; Monto A; Barber TC; Kuo AC
J Arthroplasty; 2019 Jul; 34(7S):S319-S326.e1. PubMed ID: 30930157
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Is Associated With Higher Short-Term Complication Rates After Initial Aseptic and Septic Revision Total Hip Arthroplasty: A Matched Cohort Study.
Ross BJ; Cole MW; Ross AJ; Guild GN; Lee OC; Sherman WF
J Arthroplasty; 2023 Mar; 38(3):548-554. PubMed ID: 36130698
[TBL] [Abstract][Full Text] [Related]
8. Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection.
Bedair HS; Schurko BM; Dwyer MK; Novikov D; Anoushiravani AA; Schwarzkopf R
J Arthroplasty; 2019 Jan; 34(1):132-135. PubMed ID: 30337253
[TBL] [Abstract][Full Text] [Related]
9. Short-term Complications After Revision Hip Arthroplasty for Prosthetic Joint Infection Are Increased Relative to Noninfectious Revisions.
Boddapati V; Fu MC; Tetreault MW; Blevins JL; Richardson SS; Su EP
J Arthroplasty; 2018 Sep; 33(9):2997-3002. PubMed ID: 29853307
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection increases the risk of adverse outcomes following joint arthroplasty: A meta-analysis of observational studies.
Cheng T; Yang C; Hao L; Cheng X; Hu J; Ren W; Zhang X
Orthop Traumatol Surg Res; 2022 Apr; 108(2):102947. PubMed ID: 33930585
[TBL] [Abstract][Full Text] [Related]
11. Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.
Kildow BJ; Politzer CS; DiLallo M; Bolognesi MP; Seyler TM
J Arthroplasty; 2018 Jul; 33(7S):S86-S92.e1. PubMed ID: 29198873
[TBL] [Abstract][Full Text] [Related]
12. Child-Pugh Class B or C Liver Disease Increases the Risk of Early Mortality in Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty Regardless of Treatment Status.
Cichos KH; Jordan E; Niknam K; Chen AF; Hansen EN; McGwin G; Ghanem ES
Clin Orthop Relat Res; 2023 Oct; 481(10):2016-2025. PubMed ID: 36961471
[TBL] [Abstract][Full Text] [Related]
13. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis.
Anoushiravani AA; Kalyanasundaram G; Feng JE; Congiusta F; Iorio R; DiCaprio MR
J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S84-S90. PubMed ID: 36878438
[TBL] [Abstract][Full Text] [Related]
14. Is Prior Hip Arthroscopy Associated With Higher Complication Rates or Prolonged Opioid Claims After Total Hip Arthroplasty? A Matched Cohort Study.
Ross BJ; Wortman RJ; Lee OC; Mansour AA; Cole WW; Sherman WF
Orthop J Sports Med; 2022 Sep; 10(9):23259671221126508. PubMed ID: 36199826
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort.
Waters TL; Wilder JH; Ross BJ; Salas Z; Sherman WF
J Arthroplasty; 2022 May; 37(5):892-896.e5. PubMed ID: 35026366
[TBL] [Abstract][Full Text] [Related]
16. Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: a matched control study.
Chalmers BP; Weston JT; Osmon DR; Hanssen AD; Berry DJ; Abdel MP
Bone Joint J; 2019 Jul; 101-B(7_Supple_C):91-97. PubMed ID: 31256641
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Antiviral Treatment Decreases All-Cause Complications After Total Joint Arthroplasty Regardless of the Presence of Fibrosis.
Cornell E; Novikov D; Niu R; Staatz K; Schwarzkopf R; Smith EL
J Arthroplasty; 2021 May; 36(5):1551-1555. PubMed ID: 33431189
[TBL] [Abstract][Full Text] [Related]
18. Elevated Infection and Complication Rates in Patients Undergoing a Primary THA With a History of a PJI in a Prior Hip or Knee Arthroplasty: A Matched Cohort Study.
Chalmers BP; Berbari EF; Osmon DR; Hanssen AD; Berry DJ; Abdel MP
J Arthroplasty; 2020 Jul; 35(7):1928-1932. PubMed ID: 32147342
[TBL] [Abstract][Full Text] [Related]
19. Does Symptomatic Benign Prostatic Hyperplasia Increase the Risk of Periprosthetic Joint Infection After Primary Total Joint Arthroplasty?
Gu A; Agarwal A; Fassihi SC; Bovonratwet P; Campbell JC; Sculco PK
J Arthroplasty; 2021 Mar; 36(3):897-904. PubMed ID: 33032874
[TBL] [Abstract][Full Text] [Related]
20. The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty.
Schwarzkopf R; Novikov D; Anoushiravani AA; Feng JE; Vigdorchik J; Schurko B; Dwyer MK; Bedair HS
Bone Joint J; 2019 Jun; 101-B(6):667-674. PubMed ID: 31154838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
